Patel, R., Newman, E.M., Villacorte, D.G., Sato, J.K., Reaman, G.H., Finklestein, J.Z., Krailo, M.D., Hammond, G.D., and Holcenberg, J.S.: Pharmacology and phase I trial of high-dose oral leucovorin plus 5-Fluorouracil in children with refractory cancer: A Report from the Childrens Cancer Study Group. Cancer Res. 51:4871-4875,1991.
Berg, S.L., Balis, F.M., Zimm, S., Murphy, R.F., Holcenberg, J., Sato, J.K., Reaman, G., Steinherz, P., Gillespie, A., and Doherty, K., et. al.: Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies. J Clin Oncol. 10(1):143-148, 1992.
Sato, J.K., Wiersma, S., Krailo, M., Bostrom, B., Shurin, S., Cheerva, A., Hammond, D., Avramis, V.: Phase I clinical and pharmacodynamic study of continuous infusion (CI) fludarabine followed by continuous infusion (CI) cytosine arabinoside (ara-C) in relapsed leukemia. Proc. Am. Assoc. Cancer Research 33:1266, 1992.
McIntyre, J.F., Smith-Sorensen, B., Friend, S.H., Kassell, J., Barresen, A-L., Yan, Y.X., Russo, C., Sato, J., Barbier, N., Miser, J., Malkin, D. and Gebhardt, M.C.: Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. J. Clin. Oncol. 12(5):925-930, 1994.
Crooks, M.G. and Sato, J.K., Ifosfamide and etoposide in recurrent childhood acute lymphoblastic leukemia. J. Ped. Hem. Oncol. 17(1):34-38, 1995.
Murphree, A.L., Villablanca, J.G., Deegan, W.F. 3rd, Sato, J.K., Malogolowkin, M., Fisher, A., Parker, R., Reed, E. and Gomer, C.J.: Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol. 114(11):1348-1356, 1996.
Geyer, J.R., Balis, F.M., Krailo, M.D., Heideman, R., Broxson, E., Sato, J.K., Poplack, D., and Bleyer, W.A.: A Phase II study of ThioTEPA in children with recurrent solid tumor malignancies: A Children’s Cancer Group Study. Invest New Drugs. 13(4):337-342, 1996
Dinndorf, P.A., Avramis, V.I., Wiersma, S., Krailo, M.D., Liu-Mares, W., Seibel, N.L., Sato, J.K., Moser, R.B., Kelleher, J.F., and Reaman, G.H.: Phase I/II study of idarubicin given with continuous infusion fludarabine followed by continuous infusion cytarabine in children with acute leukemia: A Report from the Children’s Cancer Group. J Clin Oncol. 15(8):2780-2785, 1997.
Avramis, V.I., Wiersma, S., Krailo, M.D., Ramilo-Torno, L.V., Sharpe, A., Liu-Mares, W., Kowck, R., Reaman, G.H., and Sato, J.K., Pharmacokinetic and pharmacodynamic studies of fludarabine and cytosine arabinoside administered as loading boluses followed by continuous infusions after a phase I/II study in pediatric patients with relapsed leukemias. Clin Cancer Res. 4(1):45-52, 1998.
Blaney, S.M., Needle, M.N., Gillespie, A., Sato, J.K., Reaman, G.H., Berg, S.L., Adamson, P.C., Krailo, M.D., Bleyer, W.A., Poplack, D.G., and Balis, F.M.: Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: A collaborative pediatric branch, National Cancer Institute, and Children’s Cancer Group Study. Clin Cancer Res. 4(2):357-360, 1998.
Roebuck, D.J., Sato, J.K., and Fahmy, J.: Breast metastasis in osteosarcoma. Australas Radiol. Feb 43(1):108-110, 1999.
Sato, J.K., Ramilo-Torno, L., Krailo, M., Carcich, S., Moser, R., Seibel, N., Steinherz, P., Reaman, G., and Avramis, V.: Phase I clinical and pharmacodynamic study of continuous infusion (CI) mercaptopurine (MP) followed by continuous infusion cytosine arabinoside (ara-C) in relapsed leukemia. Proc. Am. Soc. Clin. Oncol. 18:767, 1999.
Cairo MS, Shen V, Krailo MD, Bauer M, Miser JS, Sato JK, Blatt J, Blazar BR, Frierdich S, Liu-Mares W, and Reaman, GH: Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide carboplatin, and etoposide in children with recurrent or refractory solid tumors: A Children’s Cancer Group Report. J Pediatri. Hem. Oncol. 23(1): 30-38, 2001.
Seibel, N., Krailo, M., Sato, J., Liu-Mares, W., Drachtman, R., Greffe, G., Breitfeld, P., and Reaman, G.: Phase II window of topotecan in newly diagnosed metastatic osteosarcoma–CCG 7943. Proc Am. Soc. Clin. Oncol. 20:378a, 2001.
Meyers, P.A., Schwartz, C.L., Krailo, M., Kleinerman, E.S., Betcher, D., Bernstein, M.L., Conrad, E., Ferguson, W., Gebhardt, M., Goorin, A.M., Harris, M.B., Healey, J., Huvos, A., Link, M., Montebello, J., Nadel H., Nieder, M., Sato, J., Siegal, G., Weiner, M., Wells, R., Wold, L., Womer, R. and Grier, H.: Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J. Clin. Oncol. M.
This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 07/08.
